- Companies
- IHH Healthcare
IHH Healthcare Valuation Multiples
IHH Healthcare is valued at $17B as of October 2026, a 3.1x revenue multiple. In the last 12 months, IHH Healthcare revenue was $6.9B and IHH Healthcare EBITDA was $1.5B.
IHH Healthcare Overview
About IHH Healthcare
IHH Healthcare Bhd operates a network of healthcare clinics, hospitals, and postoperative rehabilitation centers. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The group’s reportable segments include Hospital and healthcare, Labs, PLife REIT, and Others. A majority of its revenue is generated from the Hospital and healthcare segment, which represents income generated from the provision of healthcare services through its hospitals and healthcare clinics across Singapore, Malaysia, India, Greater China, Turkiye and Europe, and Southeast Asia. Geographically, the group derives maximum revenue from Turkiye and Europe.
Founded
2010
HQ
Employees
70.0K
Website
Sectors
Financials (LTM)
EV
$21B
Valuation Multiples
Start free trialIHH Healthcare Financials
IHH Healthcare reported last 12-month revenue of $6.9B and EBITDA of $1.5B.
In the same LTM period, IHH Healthcare generated $4.9B in gross profit, $1.5B in EBITDA, and $556M in net income.
Revenue (LTM)
IHH Healthcare P&L
In the most recent fiscal year, IHH Healthcare reported revenue of $6.3B and EBITDA of $1.5B.
IHH Healthcare is profitable as of last fiscal year, with gross margin of 72%, EBITDA margin of 24%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
IHH Healthcare Stock Performance
IHH Healthcare has current market cap of $17B, and enterprise value of $21B.
Market Cap Evolution
IHH Healthcare's stock price is $1.94.
IHH Healthcare share price increased by 1.0% in the last 30 days, and decreased by 1.5% in the last year.
IHH Healthcare has an EPS (earnings per share) of $0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $21B | $17B | 0.1% | 1.0% | -5.2% | -1.5% | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIHH Healthcare Valuation Multiples
IHH Healthcare trades at 3.1x EV/Revenue multiple, and 14.0x EV/EBITDA.
EV / Revenue (LTM)
IHH Healthcare Financial Valuation Multiples
As of October 21, 2026, IHH Healthcare has market cap of $17B and EV of $21B.
IHH Healthcare has a P/E ratio of 30.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified IHH Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


IHH Healthcare Margins & Growth Rates
IHH Healthcare grew revenue by 10% and EBITDA by 2% in the last fiscal year.
In the most recent fiscal year, IHH Healthcare reported gross margin of 72%, EBITDA margin of 24%, and net margin of 8%.
IHH Healthcare Margins
IHH Healthcare Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
IHH Healthcare Operational KPIs
IHH Healthcare's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
IHH Healthcare's Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IHH Healthcare's Rule of X is 47% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
IHH Healthcare Competitors
IHH Healthcare competitors include Rede D'Or São Luiz, Dr. Sulaiman Al Habib, Tenet Healthcare, Encompass Health, Apollo Hospitals, DaVita, Aier EYE Hospital Group, Universal Health Services, Bradsaúde and Bangkok Dusit Medical Services.
Most IHH Healthcare public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $11B | $1.3B | 2.0x | 1.8x | 16.5x | 9.5x | |||
| $3.7B | $927M | 6.2x | 5.6x | 24.3x | 23.5x | |||
| $21B | $4.5B | 1.7x | 1.7x | 8.3x | 7.6x | |||
| $5.9B | $1.4B | 2.6x | 2.5x | 11.1x | 11.5x | |||
| $2.6B | $403M | 4.7x | 4.3x | 30.9x | 28.0x | |||
| $14B | $2.6B | 1.9x | 1.8x | 9.7x | 8.9x | |||
| $3.3B | $959M | 3.4x | 3.3x | 11.9x | 11.7x | |||
| $17B | $2.7B | 0.9x | 0.9x | 5.9x | 6.2x | |||
This data is available for Pro users. Sign up to see all IHH Healthcare competitors and their valuation data. Start Free Trial | ||||||||
IHH Healthcare VC Funding History
Before going public, IHH Healthcare raised funding across 1 round.
Last private valuation of IHH Healthcare was $636M, after raising a round in May 2008 from Khazanah Nasional.
IHH Healthcare Funding Rounds
Acquisitions by IHH Healthcare
IHH Healthcare has acquired 10 companies to date.
Last acquisition by IHH Healthcare was on September 4th 2024. IHH Healthcare acquired Island Hospital for $862M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by IHH Healthcare
| Description | Island Hospital is a Penang-based multispecialty healthcare provider offering diagnostics, surgery, and oncology services. Equipped with 1.5 Tesla MRI scanners, PET-CT units, and robotic surgery systems, it treats cardiology, orthopedics, and fertility cases. The 600-bed facility serves Malaysia and international patients from Indonesia and the Middle East, accredited by MSQH and JCI standards. | Bedrock Healthcare was the Malaysian holding company that owned Timberland Medical Centre in Kuching, Sarawak. Timberland is a private multidisciplinary hospital serving patients in Kuching and the wider state through inpatient, outpatient, surgical and diagnostic care. At the time of acquisition, the operating hospital had 82 licensed beds and plans for a separate 200-bed facility on an acquired development site. Patients, insurers and corporate health programs fund the hospital's clinical services. Revenue comes from treatment, procedures, consultations, diagnostics and related care. IHH acquired Bedrock to establish a larger presence in East Malaysia and integrate Timberland into its nationwide hospital network. Bedrock Healthcare serves B2C and B2B customers through activities spanning Hospitals & Clinics and Medical Imaging & Diagnostics. | Prince Court Medical Centre is a private tertiary hospital in central Kuala Lumpur, Malaysia. It offers specialist inpatient and outpatient care across areas including surgery, oncology, cardiology, orthopaedics, women's health and diagnostic medicine. Local and international patients, insurers and corporate health programs pay for clinical services delivered by its physicians and hospital teams. Revenue is generated from hospital treatment, procedures, consultations, diagnostics and related patient services. Khazanah acquired the hospital from Petronas in 2018 and subsequently sold it to its controlled IHH Healthcare platform. Under IHH ownership, Prince Court operates as a premium hospital alongside the group's Pantai and Gleneagles brands in Malaysia. | Amanjaya Specialist Centre was a private multidisciplinary hospital in Sungai Petani, Kedah, Malaysia. At acquisition it operated 98 beds and provided medical, surgical, diagnostic and specialist services to patients in northern Peninsular Malaysia. Patients and insurers paid for inpatient, outpatient and ancillary clinical care delivered by the hospital and its doctors. The facility extended IHH's Pantai hospital network into a growing secondary city and complemented its existing presence in the region. After IHH acquired the company, the hospital was integrated into Parkway Pantai and later rebranded as Pantai Hospital Laguna Merbok. It remains an operating acute-care hospital within IHH's Malaysian portfolio. Amanjaya Specialist Centre serves B2C customers through activities spanning Hospitals & Clinics and Medical Imaging & Diagnostics. | |
| HQ Country | |||||
| HQ City | Penang | Kuching | Kuala Lumpur | Sungai Petani | |
| Deal Date | 4 Sep 2024 | 29 Feb 2024 | 1 Sep 2020 | 1 Oct 2018 | |
| Valuation | $862M | $58M | $245M | $24M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all IHH Healthcare acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by IHH Healthcare
IHH Healthcare has invested in 6 companies to date.
Latest investment by IHH Healthcare was on January 29th 2026. IHH Healthcare invested in TibaRay in their Strategic investment round.
Latest Investments by IHH Healthcare
| Description | TibaRay creates ultra-fast, precise technologies to improve cancer diagnosis and treatment accuracy. | Acibadem City Clinic is a Bulgarian private healthcare network created by combining Tokuda Group with City Clinic's hospitals and outpatient centres. It provides acute hospital care, oncology, cardiovascular treatment, diagnostics and specialist outpatient services across several Bulgarian facilities. Patients, insurers and the public reimbursement system pay for clinical services delivered by its medical teams. Revenue comes from hospital admissions, procedures, consultations, diagnostics and related care. The network is held through Acibadem City Clinic B.V. and operates as part of IHH Healthcare's Acibadem regional platform. IHH increased its effective ownership in 2023 by purchasing the International Finance Corporation's minority interest in the holding company. Acibadem City Clinic serves B2C and B2B customers through activities spanning Hospitals & Clinics and Medical Imaging & Diagnostics. | Gleneagles Healthcare India is an Indian private hospital network formerly known as Global Hospitals and Gleneagles Global Hospitals. It operates multi-specialty hospitals offering complex surgery, transplantation, oncology, gastroenterology, neurosciences and other tertiary-care services. Patients, insurers and corporate health programs purchase inpatient, outpatient, diagnostic and procedural care across its facilities. Revenue is earned from hospital treatment and associated clinical services in major Indian cities. IHH first acquired control through Parkway Pantai and later increased its holding through purchases from minority shareholders. The business now operates under the Gleneagles Hospitals brand as a substantially owned component of IHH's Indian healthcare portfolio. | Doctor Anywhere is a Singapore-headquartered telehealth provider delivering video consultations, medicine delivery, and chronic care plans across Southeast Asia. The app connects users to GPs in Singapore, Malaysia, and Thailand for 24/7 access. Founded in 2017, it partners with clinics like Fullerton Health. | |
| HQ Country | |||||
| HQ City | - | Sofia | Hyderabad | Singapore | |
| Deal Date | 29 Jan 2026 | 19 Dec 2023 | 25 Sep 2023 | 21 Dec 2022 | |
| Round | Strategic investment | Secondary | Secondary | Series C | |
| Raised | undisclosed | undisclosed | undisclosed | $39M | |
| Investors | IHH Healthcare | IHH Healthcare | IHH Healthcare | Asia Partners Fund Management; Novo Holdings; IHH Healthcare; Square Peg Capital; OSK-SBI Venture Partners; EDBI; Kamet Capital Partners | |
| Valuation | undisclosed | $65M | $89M | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all IHH Healthcare investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout IHH Healthcare
| When was IHH Healthcare founded? | IHH Healthcare was founded in 2010. |
| Where is IHH Healthcare headquartered? | IHH Healthcare is headquartered in Malaysia. |
| How many employees does IHH Healthcare have? | As of today, IHH Healthcare has over 70K employees. |
| Is IHH Healthcare publicly listed? | Yes, IHH Healthcare is a public company listed on Bursa Malaysia. |
| What is the stock symbol of IHH Healthcare? | IHH Healthcare trades under 5225 ticker. |
| When did IHH Healthcare go public? | IHH Healthcare went public in 2012. |
| Who are competitors of IHH Healthcare? | IHH Healthcare main competitors include Rede D'Or São Luiz, Dr. Sulaiman Al Habib, Tenet Healthcare, Encompass Health, Apollo Hospitals, DaVita, Aier EYE Hospital Group, Universal Health Services, Bradsaúde, Bangkok Dusit Medical Services. |
| What is the current market cap of IHH Healthcare? | IHH Healthcare's current market cap is $17B. |
| What is the current revenue of IHH Healthcare? | IHH Healthcare's last 12 months revenue is $6.9B. |
| What is the current revenue growth of IHH Healthcare? | IHH Healthcare revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of IHH Healthcare? | Current revenue multiple of IHH Healthcare is 3.1x. |
| What is the current EBITDA of IHH Healthcare? | IHH Healthcare's last 12 months EBITDA is $1.5B. |
| What is IHH Healthcare's EBITDA margin? | IHH Healthcare's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of IHH Healthcare? | Current EBITDA multiple of IHH Healthcare is 14.0x. |
| What is the current FCF of IHH Healthcare? | IHH Healthcare's last 12 months FCF is $781M. |
| What is IHH Healthcare's FCF margin? | IHH Healthcare's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of IHH Healthcare? | Current FCF multiple of IHH Healthcare is 27.3x. |
| How many companies IHH Healthcare has acquired to date? | As of October 2026, IHH Healthcare has acquired 10 companies. |
| What was the largest acquisition by IHH Healthcare? | $862M acquisition of Island Hospital on 4th September 2024 was the largest M&A IHH Healthcare has done to date. |
| What companies IHH Healthcare acquired? | IHH Healthcare acquired Island Hospital, Prince Court Medical Centre, Gleneagles Global Hospitals, Fortis Healthcare, Continental Hospitals, Tokuda Group, Bedrock Healthcare, Amanjaya Specialist Centre, Angsana Molecular & Diagnostics Laboratory, and City Clinic Group. |
| In how many companies IHH Healthcare has invested to date? | As of October 2026, IHH Healthcare has invested in 6 companies. |
| What was the last IHH Healthcare investment? | On 29th January 2026 IHH Healthcare invested in TibaRay, participating in a Strategic investment round. |
| In what companies IHH Healthcare invested in? | IHH Healthcare invested in Doctor Anywhere, Lucence Health, Us2.ai, Acibadem City Clinic, Gleneagles Global Hospitals, and TibaRay. |
See public comps similar to IHH Healthcare
Lists including IHH Healthcare
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




